Kerala Ayurveda Ltd
BSE:530163
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
252.9
603.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
|
Kerala Ayurveda Ltd
BSE:530163
|
3.1B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
983.5B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
546.4B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.8B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
273.5B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
149.1B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
96.4B EUR |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Kerala Ayurveda Ltd
Glance View
Kerala Ayurveda Ltd. engages in the manufacture and sale of holistic healing and wellness products and healthcare services. The company is headquartered in Bangalore, Karnataka. The firm is primarily focused in the area of manufacture of Ayurveda products, Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services, cultivation of Ayurveda herbs and maintaining herbarium of medicinal plants. The company is primarily engaged in ayurvedic medicine and health care services and products. The Company’s product categories include diabetes, organic superfood, child/kids health, diabetes/heart health, gastro care, eye care, joint care, lifestyle products, massage oils, men’s care, renal care, respiratory and allergy, skin and hair care, women care, general health/immunity, gulika/pills/tab, arishtam, thailam, kwath tablets, and ayurveda soaps. The Company’s subsidiaries include Ayurvedagram Heritage Wellness Centre Pvt Ltd., Ayurvedic Academy Inc, Suveda Inc (formerly known as Nutraveda Inc.), Ayu Natural Medicine Clinic PS, CM S Katra Holdings LLC, and Nutraveda Pte Ltd.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Kerala Ayurveda Ltd is -20.5%, which is below its 3-year median of 1%.
Over the last 3 years, Kerala Ayurveda Ltd’s Operating Margin has decreased from 9.9% to -20.5%. During this period, it reached a low of -20.5% on Oct 30, 2025 and a high of 9.9% on Aug 30, 2022.